0001213900-24-022663.txt : 20240314 0001213900-24-022663.hdr.sgml : 20240314 20240314171210 ACCESSION NUMBER: 0001213900-24-022663 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240314 DATE AS OF CHANGE: 20240314 EFFECTIVENESS DATE: 20240314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADIAL PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001513525 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 800667150 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-507664 FILM NUMBER: 24751238 BUSINESS ADDRESS: STREET 1: 1180 SEMINOLE TRAIL STREET 2: SUITE 495 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22901 BUSINESS PHONE: 434-422-9800 MAIL ADDRESS: STREET 1: 1180 SEMINOLE TRAIL STREET 2: SUITE 495 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22901 FORMER COMPANY: FORMER CONFORMED NAME: ADial Pharmaceuticals, L.L.C. DATE OF NAME CHANGE: 20170515 FORMER COMPANY: FORMER CONFORMED NAME: Adial Pharmaceuticals, L.L.C. DATE OF NAME CHANGE: 20110218 D 1 primary_doc.xml X0708 D LIVE 0001513525 ADIAL PHARMACEUTICALS, INC. 4870 SADLER ROAD, SUITE 300 GLEN ALLEN VA VIRGINIA 23060 (804) 487-8196 DELAWARE Adial Pharmaceuticals L.L.C. ADial Pharmaceuticals, L.L.C. Adial Pharmaceuticals, L.L.C. Corporation true Cary J. Claiborne 4870 Sadler Road, Suite 300 Glen Allen VA VIRGINIA 23060 Executive Officer Director Joseph M. Truluck 4870 Sadler Road, Suite 300 Glen Allen VA VIRGINIA 23060 Executive Officer James K. Anderson 4870 Sadler Road, Suite 300 Glen Allen VA VIRGINIA 23060 Director Robertson H. Gilliland 4870 Sadler Road, Suite 300 Glen Allen VA VIRGINIA 23060 Director Bankole A. Johnson 4870 Sadler Road, Suite 300 Glen Allen VA VIRGINIA 23060 Executive Officer James W. Newman, Jr. 4870 Sadler Road, Suite 300 Glen Allen VA VIRGINIA 23060 Director Kevin Schuyler, CFA 4870 Sadler Road, Suite 300 Glen Allen VA VIRGINIA 23060 Director Tony Goodman 4870 Sadler Road, Suite 300 Glen Allen VA VIRGINIA 23060 Director Pharmaceuticals Decline to Disclose 06b false 2024-03-06 false true true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE NEW YORK NY NEW YORK 10022 NY NEW YORK false 287500 287500 0 Includes an aggregate exercise price of warrants of $0.125 true 0 1 23000 true 0 Includes cash fee equal to 7% & a 1% management fee of the aggregate gross proceeds of the private placement The issuer issued to placement agent (and warrants to purchase up to 85,106 shares at an exercise price of $3.25). 0 true While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers false ADIAL PHARMACEUTICALS, INC. /s/ Cary J. Claiborne Cary J. Claiborne Chief Executive Officer 2024-03-14